09:48 AM EST - Appili Therapeutics Inc. : Announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance of new patent claims for ATI-1501, Appili’s liquid oral reformulation of the antibiotic metronidazole. A notice of allowance is issued by the USPTO to indicate that the application has passed the examination. Appili Therapeutics Inc.
shares T.APLI are trading up $0.01 at $0.06.
